Broadfin Capital as of June 30, 2018
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 41 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 8.4 | $53M | 4.2M | 12.80 | |
| Mirati Therapeutics | 7.9 | $50M | 1.0M | 49.30 | |
| La Jolla Pharmaceuticl Com Par | 6.9 | $44M | 1.5M | 29.17 | |
| Zogenix | 6.7 | $42M | 957k | 44.20 | |
| Adamas Pharmaceuticals | 5.8 | $37M | 1.4M | 25.83 | |
| Endo International (ENDPQ) | 5.6 | $36M | 3.8M | 9.43 | |
| Corium Intl | 4.5 | $29M | 3.6M | 8.01 | |
| Retrophin | 4.5 | $29M | 1.0M | 27.26 | |
| Heron Therapeutics (HRTX) | 3.8 | $24M | 620k | 38.85 | |
| Horizon Pharma | 3.5 | $22M | 1.3M | 16.56 | |
| Catalyst Pharmaceutical Partners (CPRX) | 3.3 | $21M | 6.8M | 3.12 | |
| Aratana Therapeutics | 2.9 | $18M | 4.3M | 4.25 | |
| Flamel Technologies Sa (AVDL) | 2.6 | $17M | 2.7M | 6.13 | |
| EXACT Sciences Corporation (EXAS) | 2.5 | $16M | 261k | 59.79 | |
| Adma Biologics (ADMA) | 2.3 | $15M | 3.2M | 4.51 | |
| Strongbridge Bioph shs usd | 2.2 | $14M | 2.3M | 6.00 | |
| BioDelivery Sciences International | 2.0 | $13M | 4.3M | 2.95 | |
| Tandem Diabetes Care (TNDM) | 2.0 | $13M | 571k | 22.02 | |
| Antares Pharma | 1.9 | $12M | 4.6M | 2.58 | |
| Dentsply Sirona (XRAY) | 1.8 | $12M | 263k | 43.77 | |
| Integra LifeSciences Holdings (IART) | 1.7 | $11M | 163k | 64.41 | |
| Teligent | 1.6 | $10M | 3.0M | 3.46 | |
| Recro Pharma (SCTL) | 1.6 | $10M | 2.0M | 5.02 | |
| Kala Pharmaceuticals | 1.3 | $8.2M | 599k | 13.73 | |
| Livanova Plc Ord (LIVN) | 1.1 | $7.2M | 72k | 99.82 | |
| Noveliontherapeuti.. | 1.1 | $7.2M | 1.9M | 3.68 | |
| Mettler-Toledo International (MTD) | 1.1 | $6.9M | 12k | 578.66 | |
| Sierra Oncology | 1.0 | $6.2M | 2.1M | 2.96 | |
| Strata Skin Sciences (SSKN) | 0.9 | $6.0M | 2.9M | 2.05 | |
| Tesaro | 0.9 | $5.6M | 125k | 44.47 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.8 | $5.1M | 15M | 0.34 | |
| Sol Gel Technologies (SLGL) | 0.8 | $5.0M | 648k | 7.72 | |
| Xeris Pharmaceuticals | 0.8 | $4.7M | 250k | 18.98 | |
| Amarin Corporation (AMRN) | 0.7 | $4.5M | 1.5M | 3.09 | |
| Pacific Biosciences of California (PACB) | 0.6 | $3.7M | 1.1M | 3.55 | |
| Global Blood Therapeutics In | 0.6 | $3.6M | 80k | 45.21 | |
| Quotient | 0.6 | $3.5M | 440k | 8.03 | |
| Mediwound Ltd cmn | 0.5 | $3.3M | 477k | 6.90 | |
| Alphatec Holdings (ATEC) | 0.5 | $3.3M | 1.1M | 2.98 | |
| Scynexis | 0.5 | $3.1M | 1.9M | 1.64 | |
| Odonate Therapeutics Ord | 0.3 | $2.1M | 93k | 22.08 |
